Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10745
Title: Subxiphoid partial pericardiectomy with or without sclerosant instillation in the treatment of symptomatic pericardial effusions in patients with malignancy.
Austin Authors: Chan, A;Rischin, D;Clarke, C Peter;Woodruff, R K
Affiliation: Department of Medical Oncology, Austin Hospital, Melbourne, Australia
Issue Date: 1-Sep-1991
Publication information: Cancer; 68(5): 1021-5
Abstract: Twenty-two patients with malignant pericardial effusions were treated with subxiphoid partial pericardiectomy between 1984 and 1989. Thirteen patients also had a sclerosing agent instilled intrapericardially. Tamponade was relieved by pericardiocentesis before administration of general anesthesia. In 18 patients (82%), the effusions were controlled for longer than 30 days, and two patients died before 30 days without effusion. There were two recurrences at 1.5 and 7 months. There was one death due to hemorrhage from a laceration in a heavily infiltrated pericardium, and one patient had persistent dyspnea after the procedure. Complications included transient atrial arrhythmias (two patients), chest pain after sclerosant instillation (three patients), and fever greater than 37.5 degrees C after sclerosant (five patients). The survival range was 0.1 to 18 months (median, 5 months). Subxiphoid partial pericardiectomy with or without intrapericardial sclerosant is a safe and efficacious treatment for malignant pericardial effusions.
Gov't Doc #: 1913473
URI: http://ahro.austin.org.au/austinjspui/handle/1/10745
URL: https://pubmed.ncbi.nlm.nih.gov/1913473
Type: Journal Article
Subjects: Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Female
Humans
Male
Middle Aged
Neoplasms.complications.pathology.therapy
Pericardial Effusion.etiology.pathology.surgery.therapy
Pericardiectomy
Sclerosing Solutions.therapeutic use
Xiphoid Bone.surgery
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.